Evolve Medical Education | Hidradenitis Suppurativa Update

Supported by an educational grant from LEO Pharma.

Learning Objectives

Recognize the epidemiology of Hidradenitis Suppurativa

Recognize primary lesions at early stage of disease

Implement early diagnosis to prevent morbidity and provide effective treatment outcomes

Accreditation and Designation Statement

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Evolve Medical Education, LLC designates this live activity for a maximum of .5 AMA PRA Category 1 Credits ^TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA CONTINUING EDUCATION
PAs may claim a maximum of .5 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits^TM from organizations accredited by ACCME or a recognized state medical society.
NURSE PRACTITIONER CONTINUING EDUCATION
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits^TM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
This activity is designated for .25 pharmacology hours.

Faculty and Disclosures

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Joseph Gorelick, MSN, FNP-C has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma, Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and UCB. Advisory Board/Speaker’s Bureau: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma; Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sun Pharma, and UCB.

Accreditation and Medical Education Support Disclosure

Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report.

Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education, Dermatology Education Foundation, Physician Resources or Leo Pharma.

Forget your password?

Test

Instructions

Step 1 of 2

Profession:*
- MD/DO
- NP
- Nurse/APN
- PA/PA-C
- PharmD/RPh
- PhD
- Other
Years in Practice:*
- >20
- 11-20
- 6-10
- 1-5
- <1
- I do not directly provide care
Patients Seen Per Week with Atopic Dermatitis:*
- 0
- 1-5
- 6-10
- 11-15
- 15-20
- 20+
Patients Seen Per Week with Psoriasis:*
- 0
- 1-5
- 6-10
- 11-15
- 15-20
- 20+
Setting:*
- Solo Practice
- Community Hospital
- Government or VA
- Group Practice
- University/Teaching Hospital
- HMO/managed care
- Non-profit/community
- Other
- I do not actively practice
Models of Care:*
- Fee for Service
- ACO
- Patient-Centered Medical Home
- Capitation
- Bundled Payments
- Other

Did the program meet the following educational objectives?*

	Agree	Neutral	Disagree
Recognize the epidemiology of Hidradenitis Suppurativa
Recognize primary lesions at early stage of disease
Implement early diagnosis to prevent morbidity and provide effective treatment outcomes

Back

	Yes	No
The design of the program was effective for the content conveyed
The content supported the identified learning objectives
The content was free of commercial bias
The content was relative to your practice
The faculty was effective in presenting the material
The activity enhanced my current knowledge base
The activity provided appropriate and effective opportunities for active learning (i.e. case studies, discussion, Q&A, etc.)
You were satisfied overall with the activity
Would you recommend this program to your colleagues

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Live Conferences
Journal Articles
Web-based Content
Videos
Other

Specialty

Course Type

Specialty

Course Type

Search

Menu

Specialty

Course Type

Search

Menu

Hidradenitis Suppurativa Update

Webinar Credits: .5

Expiration Date: Sunday, October 17, 2021

Release Date: October 7, 2020

Learning Objectives

Accreditation and Designation Statement

Faculty and Disclosures

Disclaimer

Test

Instructions

Step 1 of 2

Hidradenitis Suppurativa Update

Webinar Credits: .5

Expiration Date: Sunday, October 17, 2021

Release Date: October 7, 2020

Learning Objectives

Accreditation and Designation Statement

Faculty and Disclosures

Disclaimer

Please log in to view this course

Test

Instructions

Step 1 of 2